Global X Genomics & Biotechnology ETF
GNOM
GNOM
67 hedge funds and large institutions have $30M invested in Global X Genomics & Biotechnology ETF in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less capital invested
Capital invested by funds: $35M → $30M (-$5.02M)
Holders
67
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$575K | |
| 2 | +$354K | |
| 3 | +$224K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$148K |
| 5 |
EWM
Executive Wealth Management
Brighton,
Michigan
|
+$118K |
Top Sellers
| 1 | -$1.51M | |
| 2 | -$535K | |
| 3 | -$336K | |
| 4 |
Rockefeller Capital Management
New York
|
-$205K |
| 5 |
KF
Krilogy Financial
St. Louis,
Missouri
|
-$151K |